MinichMacGregor Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,035
Closed -$210K 107
2023
Q3
$210K Hold
2,035
0.07% 89
2023
Q2
$247K Hold
2,035
0.08% 80
2023
Q1
$313K Buy
2,035
+2,005
+6,683% +$331K 0.1% 73
2022
Q4
$5.39K Buy
+30
New +$4.91K ﹤0.01% 477

Other funds holding MRNA

MinichMacGregor Wealth Management's MRNA Position: Q4 2023 in Review

MinichMacGregor Wealth Management sold out of Moderna (MRNA) in Q4 2023, closing a stake of 2,035 shares — an estimated $210K sold.

MinichMacGregor Wealth Management first reported a position in MRNA in Q4 2022 and held it in 4 quarters. The position peaked at $313K in Q1 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • MinichMacGregor Wealth Management reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • MinichMacGregor Wealth Management sold 2,035 Moderna shares in Q4 2023, an estimated $210K.
  • MinichMacGregor Wealth Management first reported a position in Moderna in Q4 2022 and held it in 4 quarters.
  • MinichMacGregor Wealth Management's Moderna position peaked at $313K in Q1 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on MinichMacGregor Wealth Management's 13F filing for Q4 2023, filed 8 Feb 2024.